Orano Med
Quy Nguyen is a Research Associate I at Orano Med since May 2021, with a background in pharmacy and research. Previous experience includes roles as a Certified Pharmacy Technician at Carie Boyd Prescription Shop and HealthRX Pharmacy, where responsibilities encompassed compounding hormone pellets and transcribing prescriptions. Prior to this, Quy worked as a Pharmacy Technician at CVS Pharmacy, handling customer service and prescription management. A tenure as a Research Technician at the Department of Veterans Affairs involved conducting laboratory experiments utilizing various techniques. Earlier positions include a Quality Control Technician at Valspar and a Teaching and Laboratory Assistant at the University of Mary Hardin-Baylor. Quy holds a Bachelor of Science in Chemistry and Biology from the University of Mary Hardin-Baylor.
Orano Med
1 followers
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.